Schizophrenia affects the life expectancy of the individual about?

NORCET 3 - 2022 (Shift-1)

Mental Health Nursing (E5)

Easy

Appeared in: NORCET 3 - 2022 (Shift-1)

Explanation

Research consistently shows that individuals with schizophrenia have a significantly reduced life expectancy, averaging 10-15 years less than the general population.
This mortality gap is primarily driven by a higher prevalence of comorbid physical illnesses, particularly cardiovascular and metabolic diseases.
Increased suicide risk, especially in the early years after diagnosis, is a major contributor to premature death.
Lifestyle factors such as high rates of smoking, poor diet, and lack of exercise, along with disparities in healthcare access, exacerbate the problem.

Option A: This range significantly underestimates the well-documented mortality gap. While better than no effect, it doesn't capture the full extent of the issue.
Option C: This is a severe underestimation of the impact of schizophrenia on lifespan. A 2-3 year reduction is not reflective of the data from large-scale population studies.
Option D: This is factually incorrect. There is overwhelming evidence from decades of research showing that schizophrenia is associated with a significant reduction in life expectancy.

Visual 1: Infographic: Factors Contributing to the Mortality Gap in Schizophrenia. This visual could use a central figure representing the patient, with arrows pointing inwards labeled with 'Cardiovascular Disease,' 'Suicide,' 'Diabetes,' 'Smoking,' and 'Healthcare Barriers' to illustrate the multi-faceted nature of the problem.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Impact of Schizophrenia on Life Expectancy as background academic context rather than a clinical decision trigger.
Nurses are on the front line of closing the mortality gap by providing integrated care that addresses both mental and physical health needs.
A key nursing responsibility is conducting regular metabolic screenings (weight, BMI, blood pressure, glucose, lipids) for patients on antipsychotic medications, which can cause metabolic syndrome.
Patient education on lifestyle modifications—such as smoking cessation, healthy diet, and exercise—is a critical nursing intervention to improve long-term health outcomes.

How to Approach the Question

First, identify the core concept of the question: the long-term physical health outcome of schizophrenia.
Recall that serious mental illnesses (SMI) are associated with significant physical health comorbidities and reduced lifespan. This allows you to eliminate the 'no affect' option immediately.
Consider the magnitude of the impact. SMI involves complex factors including suicide risk, metabolic side effects of medication, and lifestyle challenges. This points towards a substantial reduction in life expectancy, not just a few years.
Evaluate the given ranges. 10-15 years is a well-established figure in psychiatric literature for the average reduction in life expectancy for individuals with schizophrenia. The other numerical options are significant underestimations.

Concept Tested & Keywords

Q-mWjb780knCYc0RPvi_1h